Immuron Ltd. ADS (IMRN)
NCM · ADR · CUSIP 45254U101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IMRN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45254U101
Market Cap
Micro Cap
Previous Symbol
IMROY (changed 6/9/2017)
Business: Immuron Ltd. is a publicly listed Australian biopharmaceutical company focused on oral immunotherapy products for humans. Immuron has a unique and versatile technology platform that is capable of generating a wide range of products, all with a high safety profile.
Notes: 6/5/2017 -- Listing delayed for trading on NASDAQ.

Company Contact

CEO
Steven Lydeamore
CFO
Peter Vaughan
Investor Relations
646-734-7198 · peter@nwrcommunications.com.au
General Email
thomasliquard@immuron.com
SEC EDGAR Filings
View filings »